CRISPR Therapeutics
CRSP
#3203
Rank
A$6.85 B
Marketcap
A$71.89
Share price
-6.35%
Change (1 day)
10.43%
Change (1 year)

Financial Statements

Thumbnail CRISPR Therapeutics Financial Statement 2024

Financial Statement 2024

Language: English

View Financial Statement
Thumbnail CRISPR Therapeutics Financial Statement 2023

Financial Statement 2023

Language: English

View Financial Statement
Thumbnail CRISPR Therapeutics Financial Statement 2022

Financial Statement 2022

Language: English

View Financial Statement
Thumbnail CRISPR Therapeutics Financial Statement 2021

Financial Statement 2021

Language: English

View Financial Statement